<Disease><Name>HYPERGLYCINEMIA, NON-KETOTIC (NKH)</Name><Synonym>NKH; GLYCINE ENCEPHALOPATHY; GLYCINE CLEAVAGE SYSTEM DEFICIENCY</Synonym><OMIM><Number>605899</Number><URL>http://omim.org/entry/605899</URL></OMIM><Orphanet><Number>407</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=407</URL></Orphanet><Protein><Number>glycine cleavage system defect GCS (P-protein, T-protein, H-protein)</Number><URL>http://www.uniprot.org/uniprot/?query=database:(type:mim%20605899)&amp;sort=score</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>16q23.2, 9p24.1, 3p21.31</Gene><ICD>E72.5</ICD><Summary>rare (1:76000, 1:12000 northern Finland) ;autosomal recessive;atypical patients with low glycine levels in CSF and plasma, transient form has been described in 5 patients, few patients never developed seizures</Summary><Symptoms><symtomp><id>2267</id><symptom>Amino acid, spinal fluid</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3210</id><symptom>apnea</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3204</id><symptom>corpus callosum, agenesis/hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>4043</id><symptom>EEG, burst suppression [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>4044</id><symptom>EEG: hypsarrhythmia [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3922</id><symptom>hiccups</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1960</id><symptom>hydrocephalus</symptom><category>HEAD | NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1917</id><symptom>neurological deterioration / neurologic deterioration</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3696</id><symptom>pulmonary hypertension</symptom><category>CARDIOVASCULAR SYSTEM | LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1869</id><symptom>tachypnea, hyperpnea, dyspnea, hyperventilation</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1621</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>44.00</min><max>300.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1766</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>87.00</min><max>1900.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1944</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>122.00</min><max>550.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1945</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>166.00</min><max>330.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1946</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>130.00</min><max>400.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>36</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>210.00</min><max>743.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>830</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>110.00</min><max>356.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>862</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>283.00</min><max>1097.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1414</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>180.00</min><max>1633.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>1-7d</comment></metabolite><metabolite><id>1909</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>64.00</min><max>236.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1910</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>43.00</min><max>173.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1032</id><name>Glycine cleavage enzyme</name><specimen>liver</specimen><value>decreased</value><min>2.10</min><max>4.60</max><unit>nmol/mg protein per hour</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1033</id><name>Glycine cleavage enzyme</name><specimen>lymphoblasts</specimen><value>decreased</value><min>4.40</min><max>29.00</max><unit>pmol/mg protein per hour</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>35</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>230.00</min><max>500.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>474</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.90</min><max>10.00</max><unit>&#956;mol/l</unit><age>3m-10years</age><method /><comment /></metabolite><metabolite><id>977</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>100.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>738</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.02</min><max>0.04</max><unit>ratio</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1272</id><name>Glycine</name><specimen>blood</specimen><value>increased</value><min>85.10</min><max>536.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1273</id><name>Glycine</name><specimen>serum</specimen><value>increased</value><min>144.67</min><max>911.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6804</id><title>Nonketotic Hyperglycinemia</title><author>Van Hove JLK,</author><journal>GeneReviews&#174; [Internet]</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4125</id><title>[Clinical and molecular genetic characteristics of nonketotic hyperglycinemia]</title><author>Li HF</author><journal>Zhongguo Dang Dai Er Ke Za Zhi</journal><year>2017</year><book /><volume>19</volume><number>3</number><pages>272-274</pages><co_aut /></literature><literature><id>4126</id><title>Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease</title><author>Bravo-Alonso I,</author><journal>Hum Mutat</journal><year>2017</year><book>Hum Mutat</book><volume>38</volume><number>6</number><pages>678-691</pages><co_aut>et al.</co_aut></literature><literature><id>4127</id><title>The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT</title><author>Coughlin CR 2nd,</author><journal>Genet Med</journal><year>2017</year><book /><volume>19</volume><number>1</number><pages>104-111</pages><co_aut>et al.</co_aut></literature><literature><id>5739</id><title>A novel mutation in the glycine decarboxylase gene in patient with non-ketotic hyperglycinemia</title><author>Kose E,</author><journal>Neurosciences (Riyadh)</journal><year>2017</year><book /><volume>22</volume><number>2</number><pages>131-133</pages><co_aut>et al.</co_aut></literature><literature><id>4128</id><title>Non-ketotic hyperglycinaemia: case report and review of medical literature</title><author>Madu AE1,</author><journal>J Matern Fetal Neonatal Med</journal><year>2013</year><book /><volume>26</volume><number>5</number><pages>537-539</pages><co_aut>Oliver L</co_aut></literature><literature><id>4122</id><title>Nonketotic hyperglycinemia presenting as pulmonary hypertensive vascular disease and fatal pulmonary edema in response to pulmo</title><author>Men&#233;ndez Suso JJ,</author><journal>J Pediatr</journal><year>2012</year><book /><volume>161</volume><number>3</number><pages>557-559</pages><co_aut>et al.</co_aut></literature><literature><id>2885</id><title>Nonketotic hyperglycinemia and acquired hydrocephalus</title><author>Yis U</author><journal>Pediatr Neurol</journal><year>2009</year><book /><volume>40</volume><number>2</number><pages>138-140</pages><co_aut>Kurul SH, Dirik E</co_aut></literature><literature><id>4123</id><title>Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A p</title><author>Rodr&#237;guez CE,</author><journal>Proteomics Clin Appl</journal><year>2009</year><book /><volume>3</volume><number>12</number><pages>1430-1439</pages><co_aut>et al.</co_aut></literature><literature><id>2886</id><title>Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia</title><author>Kikuchi G</author><journal>Proc Jpn Acad Ser B Phys Biol Sci</journal><year>2008</year><book /><volume>84</volume><number>4</number><pages>246-263</pages><co_aut>et al.</co_aut></literature><literature><id>2599</id><title>Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation</title><author>Korman SH</author><journal>Ann Neurol</journal><year>2006</year><book /><volume>59</volume><number>2</number><pages>411-415</pages><co_aut>et al.</co_aut></literature><literature><id>2625</id><title>Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy</title><author>Conter C</author><journal>J Inher Met Dis</journal><year>2006</year><book /><volume>29</volume><number>0</number><pages>135-142</pages><co_aut>et al.</co_aut></literature><literature><id>4124</id><title>Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension</title><author>del Toro M,</author><journal>Ann Neurol</journal><year>2006</year><book /><volume>60</volume><number>1</number><pages>148-152</pages><co_aut>et al.</co_aut></literature><literature><id>2446</id><title>Glycine decarboxylase mutations: a distinctive phenotype of nonketotic hyperglycinemia in adults</title><author>Dinopoulos A</author><journal>Neurology</journal><year>2005</year><book /><volume>64</volume><number>7</number><pages>1255-1257</pages><co_aut>et al.</co_aut></literature><literature><id>2447</id><title>Structure of P-protein of the glycine cleavage system: implications for nonketotic hyperglycinemia</title><author>Nakai T</author><journal>EMBO J</journal><year>2005</year><book /><volume>24</volume><number>8</number><pages>1523-1536</pages><co_aut>et al.</co_aut></literature><literature><id>2489</id><title>Autistic spectrum disorder: atypical presentation of non-ketotic hyperglycinaemia and maple sirup urine disease?</title><author>Keng WT</author><journal>J Inher Met Dis Suppl 1 (SSIEM 42st Annual Symposium Paris)</journal><year>2005</year><book /><volume>28</volume><number>0</number><pages>52</pages><co_aut>et al.</co_aut></literature><literature><id>2448</id><title>Natural history of nonketotic hyperglycinemia in 65 patients</title><author>Hoover-Fong JE</author><journal>Neurology</journal><year>2004</year><book /><volume>63</volume><number>10</number><pages>1847-1853</pages><co_aut>et al.</co_aut></literature><literature><id>2449</id><title>Glycine encephalopathy (nonketotic hyperglycinaemia) : review and update</title><author>Applegarth DA</author><journal>J Inherit Metab Dis</journal><year>2004</year><book /><volume>27</volume><number>32</number><pages>417-422</pages><co_aut>Toone JR</co_aut></literature><literature><id>2450</id><title>Mild variant of nonketotic hyperglycinemia with typical neonatal presentations: mutational and in vitro expression analyses in </title><author>Kure S</author><journal>J Pediatr</journal><year>2004</year><book /><volume>144</volume><number>6</number><pages>827-829</pages><co_aut>et al.</co_aut></literature><literature><id>2451</id><title>Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation</title><author>Korman SH</author><journal>Ann Neurol</journal><year>2004</year><book /><volume>56</volume><number>1</number><pages>139-143</pages><co_aut>et al.</co_aut></literature><literature><id>363</id><title>Nonketotic hyperglycinemia: atypical clinical and biochemical manifestations</title><author>Steiner RD</author><journal>J Pediatr</journal><year>1996</year><book /><volume>128</volume><number>0</number><pages>243-246</pages><co_aut>et al.</co_aut></literature><literature><id>640</id><title>Prognostic clues and outcome of early treatedment of nonketotic hyperglycinemia</title><author>Boneh A</author><journal>Pediatr Neurol</journal><year>1996</year><book /><volume>15</volume><number>0</number><pages>137-141</pages><co_aut>Degani Y, Harari M</co_aut></literature><literature><id>49</id><title>Ketamine and strychnine treatment of an infant with nonketotic hyperglycinaemia</title><author>Tegtmeyer-Metzdorf H</author><journal>Eur J Pediatr</journal><year>1995</year><book /><volume>154</volume><number>0</number><pages>649-653</pages><co_aut>Roth B, G&#252;nther M, Theisohn M, Heinemann U, Adams HA, Sticht G</co_aut></literature><literature><id>77</id><title>Nonketotic hyperglycinemia</title><author>Hamosh A,</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1337-1348</pages><co_aut>Johnsten MV, Valle D</co_aut></literature><literature><id>435</id><title>Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia</title><author>van Hove JL</author><journal>Am J Med Genet</journal><year>1995</year><book /><volume>59</volume><number>4</number><pages>444-453</pages><co_aut>et al.</co_aut></literature><literature><id>30</id><title>Blindness due to non-ketotic hyperglycinemia: report of a 38-year-old, the oldest case to date</title><author>Tanaka Y</author><journal>Intern Med</journal><year>1993</year><book /><volume>32</volume><number>8</number><pages>641-642</pages><co_aut>Miyazaki M, Tsuda M, Murai K, Kuzuhara S</co_aut></literature></Literatures></Disease>